Page results
-
UCLH has recruited the first patient in Europe for an early phase trial of a potential new medicine for patients that have a specific sub-type of multiple myeloma (MM), a type of bone marrow cancer.
-
Holistic Needs Assessment (HNA): Information for people affected by cancer and blood conditions patient information leaflet
-
Having proton beam therapy under general anaesthetic: information for children aged 1- 4 patient information
-
Having proton beam therapy under general anaesthetic: information for children aged 5-8 patient information
-
Read more about the NHS Staff Survey 2024 - we’re the top acute trust to work at for third year running!
-
The Clinical Research Facility at UCLH has been awarded £10 million in funding to deliver cutting edge early phase health research in areas including cancer and dementia.
-
CAMLIS is the Royal London Hospital for Integrated Medicine (RLHIM) Complementary and Alternative Medicine Information and Library Service and is situated on the ground floor of the hospital.
-
King Charles III and Queen Camilla met patients and families living with cancer to hear their hopes and fears as they received care at UCLH in London today.
-
Our staff have rated UCLH as the top trust in London to work at, and the third best in the country, during what has been another incredibly challenging year.
-
North Mid, UCLH and Whittington Health are running a fun, uplifting, informative event for people with sickle cell on Saturday 25th June 2022.
File results
-
FOI/2023/0461 - UCLH operating system software/ data centres hybrid cloud
-
FOI/2023/0462 - Patients to hotels
-
FOI/2023/0463 - Extravasation injuries
-
FOI/2023/0466 - Language services (interpreting and translation services)
-
FOI/2023/0471 - Treatment of HIV & PrEP
-
FOI/2023/0473 - Treatment for myelofibrosis
-
FOI/2023/0474 - Number of live births, still births and neonatal deaths
-
FOI/2023/0475 - Agency usage for the decontamination department
-
FOI/2023/0476 - Single longest wait in A&E for mental health related issue
-
FOI/2023/0478 - Social media management platform